All In MedTech

Device Trial Radar · NCT02724631

TubeClear® Evaluation in Pediatric Patients (Phase I)

Evaluation of Efficacy of Use of TubeClear® to Restore Patency to Occluded Enteral Access Devices in Pediatric Patients (Phase I)

Last checked: Nov 20, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

1

Actual

Start

Nov 2016

Primary completion

Apr 5, 2019

Study completion Jul 7, 2020

Sponsor

Lead sponsor
Children's Hospital of PhiladelphiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Actuated Medical, Inc.; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Mar 31, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is the first of three planned phases designed to evaluate the feasibility and tolerability of TubeClear® to restore patency in occluded Pediatric Enteral Access Devices. Based on preliminary data obtained from this phase of the study, subsequent phases will continue to evaluate feasibility and tolerability (Phase IIA) and ultimately compare efficacy of TubeClear® to the Children's Hospital of Philadelphia (CHOP) Standard Treatment to restore patency in occluded Pediatric Enteral Access Devices (EAD) (Phase IIB).

Conditions

  • Enteral Nutrition

Interventions

  • TubeClear® interventionDevice

    The TubeClear® device is deemed by the Food and Drug Administration (FDA) to be non-significant risk (NSR) for use in this study. It is a control box and a single use clearing stem used to resolve the clog in an enteral access device within five minutes following the intervention.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Successful Attempts to Restore EAD(P) PatencyTime frame: Baseline to 5 minutes post-intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.